Study design (if review, criteria of inclusion for studies)
Observational study
Participants
66 CF patients and 59 controls
Interventions
liver elastography (Fibroscan)
Outcome measures
The measurements were compared to clinical data, bi-yearly biochemistry and ultrasound
Main results
Fibroscan was easy to perform in this patient population. There were 14 patients (21%) with abnormal liver stiffness measurements. Liver stiffness was significantly increased in patients with clinical CFLD (11.2 kPa versus 5.1 kPa), biochemical CFLD (7.4 kPa versus 5.4 kPa) or ultrasonographical CFLD (8.2 versus 4.3 kPa) (p<0.02 for all).
Authors' conclusions
Fibroscan is an objective measure and is easy to perform in CF patients, even in children and could provide a valuable tool to detect, and quantify CFLD.